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Abstract
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Inhibitor of differentiation (Id) proteins are DNA-binding transcription factors involved in cellular
proliferation, migration, inflammation, angiogenesis and fibrosis. However, their expression and
role in the cornea is unknown. The present study was undertaken to characterize the expression of
Id proteins and their interactions with the pro-fibrotic cytokine Transforming Growth Factor β1
(TGFβ1) and anti-fibrotic cytokine, bone morphogenic protein 7 (BMP7) in human cornea. Human
donor corneas procured from Eye Bank were used. Id proteins were localized in human corneal
sections using immunofluorescence. Primary cultures of human corneal fibroblasts (HCF) were
established and treated with either TGFβ1 (5 ng/ml) or BMP7 (10 ng/ml) for 24 h in serum free
medium. Expression of Id’s in response to TGFβ1, BMP7 and TGFβ1 + BMP7 was analyzed by
quantitative real time PCR (qRT-PCR) and western blot analysis. Id1 and Id2 proteins were
ubiquitously expressed in the epithelial cells and stromal keratocytes in human cornea. The Id1
was localized to the basal epithelial cells as seen by immunohistochemistry. HCF expressed all
known mammalian Id genes (Id1–Id4). In addition, Id1 and Id2 are selectively expressed in HCF.
Treatment of human recombinant TGFβ1 (5 ng/ml) to serum-starved HCF showed a significant
increase in Id genes (Id1, Id2 and Id4) at 2 h time point compared to BMP7 treatment, which
showed time dependent increase in the expression of Id1–Id3 at 24–48 h. Combined treatment
with TGFβ1 + BMP7 to HCF showed a significant increase in Id1 transcript and an increasing
trend in Id3 and Id4 expression. The results of this study suggest that Id family of genes (Id1–Id4)
are localized in the human cornea and expressed in the corneal fibroblasts. Also, Id’s were
differentially regulated with TGFβ1 and/or BMP7 in a time dependent manner and might serve as
a therapeutic target in corneal fibrosis.
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1. Introduction

Author Manuscript

The corneal wound healing mechanism is a remarkably complex cascade mediated by
cytokines, growth factors, and chemokines including transforming growth factor (TGF)-β1,
interleukin (IL)-1β, connective tissue growth factor (CTGF), epidermal growth factor (EGF),
platelet derived growth factor (PDGF), and so on (Tandon et al., 2010; Stapleton et al., 2008;
Gibson et al., 2014; Wang et al., 2013; Kaur et al., 2009). TGFβ1 is arguably the most
important cytokine involved in wound repair and many other vital pre- and postnatal
physiological processes such as cellular proliferation, migration, differentiation, apoptosis,
and extracellular matrix (ECM) production in the corneal tissue (Izumi et al., 2006;
Kinoshita et al., 2007; Veerasamy et al., 2013). It is well established that both the corneal
epithelium and stroma express TGFβ receptors and their ligands to control variety of cellular
functions, the most important being the transdifferentiation of quiescent keratocytes to
myofibroblasts during corneal wound healing. Following stromal injury, keratocytes adjacent
to the wound migrate to the injury site and differentiate into post-mitotic α-smooth muscle
actin (α-SMA) expressing myofibroblasts in the presence of TGFβ1 (Myrna et al., 2009).
These activated myofibroblasts have contractile properties that assist in wound closure, and
secrete extra cellular matrix proteins that aid in tissue remodeling (Myrna et al., 2009;
DelMonte and Kim, 2011). However corneal fibrosis occurs when this process fails to
terminate and results in myofibroblast-induced excessive deposition of irregular ECM, scar
formation and hence vision impairment (Myrna et al., 2009; Honda et al., 2013).

Author Manuscript

Bone morphogenetic proteins (BMPs) are members of the TGFβ superfamily involved in the
embryonic development and cellular proliferation, differentiation, and apoptosis. Several
BMPs and their receptors have been described in human corneal epithelium and stroma (You
et al., 1999). Among other BMP family members, BMP7 has been shown to play a pivotal
role in eye development during embryogenesis and BMP7-knockout mice exhibits an
ophthalmic phenotype. In the cornea, therapeutic effects of BMP7 have been examined via
nanoparticle-mediated gene transfer using a rabbit corneal fibrosis model in vivo (Tandon et
al., 2013). BMP7 has been reported to oppose TGFβ biological activity via Smad signaling
and attenuates TGFβ1 hyperactivity-driven fibrosis (Tandon et al., 2013). Many recent
studies suggest that inhibitor of differentiation proteins are the crucial targets of BMP7 to
confer anti-fibrotic responses in non-ocular tissues (Miyazono and Miyazawa, 2002).
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Till today, four Id genes (Id1–Id4) have been identified in mammals. They have been
recognized as the functional inhibitors of the basic helix–loop–helix (bHLH) transcription
factors. The crucial biochemical attribute of Id genes to their DNA binding activity is to
regulate cell fate, differentiation and proliferation (Norton, 2000). The Id1 and Id3 double
knockout mice exhibit small brain, impaired angiogenesis, hemorrhage in forebrain,
premature exit of neuroblasts from the cell cycle, and death at 13.5 embryonic day
suggesting that Id proteins play an important role in embryonic development and tissue
regeneration (Lyden et al., 1999; Miyazono and Miyazawa, 2002). Most importantly, Id
proteins have been demonstrated to attenuate fibrosis in a variety of animal models including
pulmonary (Izumi et al., 2006), hepatic (Kinoshita et al., 2007), and renal tissues
(Veerasamy et al., 2013). In fact, Id gene levels have been shown to be regulated positively
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by BMP7 and negatively by TGFβ1 but not by TGFβ2 or TGFβ3 (Nagata and Todokoro,
1994; Neuman et al., 1995; Norton, 2000). However, no data exists on Id genes expression in
cornea and their role in corneal fibrosis to the best of our knowledge. In this study, we
characterized mRNA and protein expression of Id genes in human cornea and their
regulation in the presence of TGFβ1 and/or BMP7 stimulation in an in vitro model of
corneal fibrosis using cultured primary human corneal fibroblasts.

2. Materials and methods
2.1. Human cornea

Author Manuscript

All experiments in the study adhered to the tenets of the Declaration of Helsinki as a
statement of ethical principles for medical research involving human subjects and guidelines
of the Institutional Review Board of the University of Missouri. Healthy human corneal rims
were procured from the Saving Sight (Kansas City, Missouri) and handled as described
previously (Sharma et al., 2009). Corneal rims were either excised for primary human
cornea fibroblasts or processed for immunohistochemistry.
2.2. Primary human corneal fibroblasts (HCF)
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Human corneal fibroblasts were generated from human donor corneal rims (n = 6). Briefly,
corneal tissues were washed with sterile cell culture medium, and the epithelium and
endothelium were removed by gentle scraping with a scalpel blade. The corneal stroma was
cut into small pieces, placed on culture dish and incubated in humidified 5% CO2 incubator
at 37 °C in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum for 2–4 weeks until 100% confluence. The HCF cultures were harvested from
corneal buttons, grown in six-well plates in DMEM supplemented with 10% fetal bovine
serum to obtain fibroblast cultures. To generate myofibroblasts, HCF were initially seeded in
DMEM medium containing 10% serum, switched to serum-free medium containing TGFβ1
(5 ng/ml) after 12–14 h, and grown for 5 days by feeding fresh serum-free medium and
TGFβ1 every 24 h. Seventy percent confluent corneal fibroblast and myofibroblast cultures
were used for experimentation.
2.3. Immunohistochemistry

Author Manuscript

Normal human corneas were snap frozen, embedded in optimal cutting temperature (OCT)
solution, and cryosectioned at 7 μm thickness using a Microm HM525 cryostat
(ThermoFisher Scientific, Waltham, MA). Sections were rinsed in 1 × PBS for 5 min at
room temperature, outlined with a pap pen, and blocked using 5% normal donkey serum
(Jackson Immuno Research Laboratories, Inc., West Grove, PA). Tissue sections were then
subjected to single immunostaining using either anti-Id1 (1:20 dilution, Abcam®
Cambridge, MA) or anti-Id2 (1:200 dilution, Abcam® Cambridge, MA). Secondary
antibody Alexa Flour® 488 donkey anti-mouse or anti-goat (Invitrogen, Eugene, OR) was
used, respectively.
For double immunohistochemistry, HCF were treated with TGFβ1 as described above, and
fixed with ice-cold methanol for 15 min. Cells were then washed and blocked in 5% normal
donkey Serum (Jackson Immuno Research Laboratories, Inc., West Grove, PA) with 0.1%
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Tween 20 (Sigma–Aldrich, St Louis, MO) for 1 h at room temperature, followed by Id1
(1:20 dilution, Abcam® Cambridge, MA) or Id2 (1:200 dilution, Abcam® Cambridge, MA)
with mouse monoclonal αSMA antibody (1:200 dilution, Dako, Carpinteria, CA) for 90 min.
Primary antibodies were removed and cells were rinsed 3 times in 1 × PBS for 10 min s each
rinse. Cells were then incubated in secondary antibodies Alexa Flour® 488 donkey antimouse (Invitrogen, Eugene, OR) and Alexa Flour® 594 donkey anti-goat (Invitrogen,
Eugene, OR) for 1 h at room temperature. The cells were washed three times in PBS,
mounted in Vectashield containing 4′-6-diamidino-2-phenylindole (DAPI; Vector
Laboratories), and photographed with a Leica DM 4000B fluorescent microscope (Leica,
place, state, country) equipped with a digital camera (SpotCam RT KE).
2.4. Human recombinant TGFβ1 and BMP7 treatments
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Human corneal fibroblasts were platted in six well culture dishes at density of 7.5 × 104
using medium supplemented with 10% serum, and after 12–14 h switched to serum-free
medium. Cultures at 70% confluence were treated either with vehicle, human recombinant
TGFβ1 (5 ng/ml) (PeproTech, Inc. Rocky Hills, NJ), or human recombinant BMP7 (10
ng/ml) (Pepro Tech, Inc. Rocky Hills, NJ) or TGFβ1 (5 ng/ml) + BMP7 (10 ng/ml)
combination for 2, 12, 24, or 48 h. Thereafter, cultures were washed twice with cold 1×
PBS, mRNA were isolated and converted into cDNA for quantitative real-time PCR
analysis. Each treatment had 4 replicates in 6-well culture dish. Samples were run in
triplicate in every qPCR reaction, and qPCR were repeated thrice.
2.5. Quantitative real-time polymerase chain reaction
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Total RNA was isolated using RNeasy kit (Qiagen, Valencia, CA) according to the
manufacturer’s protocol. First strand cDNA was synthesized by reverse transcriptase
enzyme (Promega, Madison, WI). qRT-PCR was performed using the One Step Plus RealTime PCR system (Applied Biosystems, Carlsbad, CA). Table 1 lists the gene specific
primers used in the reverse transcription PCR and qRT-PCR. 20 μl reaction mixtures
containing 1 μl cDNA, 2 μl forward and 2 μl reverse primer, 10 μl iQ™ SYBR® Green
Super mix (Bio-Rad Laboratories, Hercules, CA) using the following PCR parameters:
95 °C for 5 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. The
fluorescence threshold value (Ct) was calculated to detect differences in signal associated
with exponential increase of PCR products in the log linear phase. Relative expression/fold
change over the corresponding values for the control was calculated by the 2−ΔΔCt method.
Two to three independent experiments were executed, and qRT-PCR reactions were ran in
triplicates for each sample, and the average fold changes in mRNA levels were calculated
(see Table 2).
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Conventional polymerase chain reaction was performed in 50 μl reaction mixtures
containing 10 μl buffer (5× green GoTaq® Flexi Buffer, Promega, Madison, WI), 8 μl MgCl2
(Promega, Madison, WI), 1 μl dNTP mix (Promega, Madison, WI), 1 μl forward and 1 μl
reverse primers (0.4 μM each), 0.25 μl GoTaq®Flexi DNA (Promega, Madison, WI), 26.75
μl DEPC treated water and 2 μl of cDNA. Cycle details include: 95 °C for 2 min, followed
by 40 cycles of 95 °C for 30 s, 50 °C for 30 s, 72 °C for 1 min, 95 °C for 1 min, and a final
cycle of 72 °C for 10 min. Primers used in this study are listed in Table 1. β-actin was used
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as a housekeeping gene. The digital quantification of RT-PCR amplification was performed
using NIH Image J software and Image Studio software Version 5.2.
2.6. Western blot analyses

Author Manuscript

Human corneal fibroblasts were seeded at an initial density of at 7.5 × 104 using medium
supplemented with 10% serum, and switched to serum-free medium when reached 50%
confluence. Cultures at 70% confluence were treated with either vehicle, recombinant
human TGFβ1 (5 ng/ml) (Pepro Tech, Inc. Rocky Hills, NJ) and/or recombinant human
BMP7 (10 ng/ml) (Pepro Tech, Inc. Rocky Hills, NJ) for 48 h. Protein lysates were prepared
and quantified by Bradford assay as described previously (Sharma et al., 2009; Hogg et al.,
2010). Samples were resolved on 4–12% sodium dodecyl sulfate (SDS) polyacrylamide gel,
transferred onto polyvinylidene fluoride membrane, incubated with Id1, Id2, β-actin (Santa
Cruz Biotechnology, Santa Cruz, CA) and α-SMA (Abcam, Cambridge, MA) antibodies
followed by alkaline phosphatase-conjugated anti-mouse secondary antibodies and Nitroblue tetrazolium chloride and 5-Bromo-4-chloro-3′-indolyphosphate p-toluidine (NBTBCIP) developing reagents. The digital quantification of western blots was performed using
NIH Image J software and Image Studio software Version 5.2.
2.7. Statistical analysis
Data was analyzed for one-way ANOVA using GraphPad Prism 6.0 (GraphPad Software,
Inc., La Jolla, CA) and p < 0.05 was considered to be statistical significant.

3. Results
Author Manuscript

3.1. Id1 and Id2 are expressed in human cornea and localized in the epithelium and stromal
keratocytes
Human corneal sections were subjected to immunohistochemistry with antibodies against
Id1 and Id2 (Fig. 1). Id1 and Id2 were detected in keratocytes throughout the stroma in the
human cornea as evident from Fig. 1A and B, respectively. Both the proteins were
differentially expressed in the corneal epithelial cells where Id1 was expressed in the basal
cells of the corneal epithelium (Fig. 1A), while Id2 was distributed throughout the corneal
epithelium (Fig. 1B). Fig. 1C and D show expression of Id1 and Id2 in the stroma and
corneal endothelium, respectively. Fig. 1E and F show cytoplasmic and nuclear staining of
Id1 and Id2 in entire cornea, respectively.
3.2. Primary human corneal fibroblasts (HCF) expressed all the members of mammalian Id
genes
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To evaluate the expression of Id genes in corneal fibroblasts, we obtained cDNA from two
different batches of cultured primary human corneal fibroblasts (HCF) and analyzed by PCR
with primers against the four known Id genes (Id1–Id4). Our results showed that all four Id
genes were expressed in corneal fibroblasts (Fig. 2). β-actin was used as an internal control.
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3.3. Id proteins are selectively expressed in corneal fibroblasts and not in myofibroblasts
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To explore the role of Id proteins in the differentiation of fibroblast to myofibroblasts,
corneal fibroblast cells were treated with TGFβ1 as described, and subjected to double
immunostaining by α-SMA and Id1 or Id2 (Fig. 3). Both Id1 and Id2 panels showed
expression in the cytoplasm and not co-stained with α-SMA staining. This suggests that
differentiated fibroblasts (or myofibroblasts) do not express these Id proteins. Contrary to Id
1–4 mRNA expression in HCF, we were unable to detect Id3 and Id4 in HCF grown with or
without TGFβ1 because of the unavailability of suitable antibodies against these proteins.
3.4. Id genes are differentially expressed by TGFβ1 and BMP7 in a time-dependent manner
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To assess changes in the Id 1–4 gene expression in response to TGFβ1 and BMP7 in the
cornea, HCF cultures at 70% confluence were treated with TGFβ1 (Fig. 4) or BMP7 (Fig. 5)
recombinant protein, and harvested at 2, 12, 24, or 48 h. The mRNAs from each time point
were isolated, converted to cDNA, and analyzed via qRT-PCR.
Fig. 4 shows that Id genes 1–4 were differentially expressed by the HCF in a time dependent
manner in response to TGFβ1 and BMP7 treatments. Shortly after TGFβ1 stimulation (2 h),
Id 1–3 gene expression peaked significantly (Id1, p < 0.001; Id2, p < 0.01 and Id4, p <
0.001) followed by a decrease in mRNA expression at tested longer time points (12, 24, and
48 h). There was an increasing trend in Id3 with TGFβ1 treatment but was not significant in
any other measured time points. On the other hand as evident from Fig. 5, BMP7 treatment
showed a gradual increase in the expression of Id1 (24 h, p < 0.005; 48 h, p < 0.001), Id2 (24
h, p < 0.01) and Id3 48 h (p < 0.001) in a time-dependent manner. Id4 transcripts showed no
changes with time after BMP7 treatment.
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3.5. TGFβ1 and BMP7 regulates Id gene expression at different time points
Id’s were activated by both TGFβ1 and BMP7 in a time-dependent manner where TGFβ1
acts as early regulator and BMP7 stimulates at later stages suggesting that Id genes responds
to growth factors differently based on their function. Next, we studied the effect of costimulation of with TGFβ1 and BMP7 treatments for 48 h (Fig. 6). We found a significant
increase in the expression of Id1 (p < 0.01). There was an increasing trend in the expression
of Id2, Id3 and Id4 but was not significant compared to control. This effect could be due to
the late effect of BMP7 observed earlier (Fig. 5). Since TGFβ1 is known activator of α-SMA
in corneal fibroblasts and BMP7 counteracts this increase we measured α-SMA transcript
and as expected found no increase in its activity (Fig. 6).
3.6. BMP7 stimulates Id protein expression in the presence of TGFβ1
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Finally, we examined the Id1 and Id2 protein expression induced by BMP7 in the presence
or absence of TGFβ1 stimulation (Fig. 7). Our results showed both Id1 and Id2 were up
regulated in response to TGFβ1 and BMP7 treatments. In addition, co-stimulation of HCF
significantly increased Id1 and Id2 proteins. On the contrary, TGFβ1 alone increased α-SMA
expression and has minimal effects on α-SMA in presence of BMP7 alone or in combination
with BMP7 treatments. These results suggest that Id1 and Id2 are dynamically regulated by
TGFβ1 and BMP7 in HCF.
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4. Discussion
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Inhibitor of differentiation genes are helix-loop-helix proteins that bind to nuclear
transcription factors and subsequently control gene expression by creating a nuclear
environment permissive to cell growth and proliferation (Norton et al., 1998). Previous
studies indicated that Id’s are actively involved in the BMP7 signaling pathway and have
been implicated for their anti-fibrotic properties in multiple organ systems (Izumi et al.,
2006). The role of Id genes in corneal homeostasis and pathology has not yet explored. In
this study, we successfully demonstrated the mRNA and protein expression of Id genes in
human cornea. Id1 and Id2 proteins are ubiquitously present in the corneal epithelial,
stromal kereatocytes and endothelial cell layers. However, the staining pattern differed
within the epithelial layer with Id2 being distributed throughout the epithelia whereas Id1
was localized in the basal and squamous cells. While Id expression studies in adult tissues
are limited, it has been reported that Id expression levels are distinct, indicating that each Id
was expressed at varying levels in a cell-type dependent manner (Hogg et al., 2010; Du and
Yip, 2011). Furthermore, it is possible that each Id protein preferentially binds to distinct
targets, thus having a specific function, which needs to be seen in the corneal cells.
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During corneal wound healing, the activation of fibroblasts by TGFβ1 is accompanied by
their transformation into α-smooth muscle actin (α-SMA) expressing contractile
myofibroblasts (Serini and Gabbiani, 1999) that are thought to be responsible for
extracellular matrix deposition and wound contraction. One of the remarkable findings in
this study is the expression of Id1 and Id2 proteins in fibroblasts and not in myofibroblasts.
It has been known that overexpression of Id proteins delay the onset of differentiation in
muscle cells (Jen et al., 1992). Id genes are mostly expressed in undifferentiated, selfrenewing populations, and are downregulated as cells differentiate and exits the cell cycle
(Norton et al., 1998). This supports our findings in human cornea where Id1 and Id2
expression was limited to keratocytes and self-renewing epithelial cells.
BMP7 protein has been reported to have anti-fibrotic properties in many organ fibrosis
systems including cornea by antagonizing TGFβ1 signaling (Tandon et al., 2013;
Weiskirchen and Meurer, 2013). We tested the hypothesis that BMP7 and TGFβ1 signaling
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pathways regulate transdifferentiation of corneal fibroblast to myofibroblast via Id proteins.
We found that HCF expressed all four known mammalian Id genes, Id1–Id4. TGFβ1
treatment to HCF showed an acute response in 2 h with the increase in Id1, Id2 and Id4
genes with progressive decrease within 48 h. Previous studies have shown that quiescent
cells expressed low-to-undetectable levels of Id genes but following mitogenic stimulation to
fibroblasts, Id expression was rapidly induced (within 2 h) as part of a cascade of ‘delayed’
early response genes. On the contrary, HCF treated with human recombinant BMP7 showed
a time-dependent increase in the expression of Id1, Id2 and Id3 transcripts with highest
levels observed in 24–48 h. Previous reports indicated that in vitro, BMP7 has been shown to
inhibit (Izumi et al., 2006) and reverse (Zeisberg et al., 2003) TGFβ1-mediated
myofibroblast activation. In addition, HCF treated with a combination of TGFβ1 + BMP7
treatment showed significant increase in Id1 accompanied by low levels of α-SMA
expression suggesting anti-fibrotic effects of BMP7 in the presence of TGFβ1. These
intriguing findings led to postulate that Id proteins act as a molecular switch, and determine

Exp Eye Res. Author manuscript; available in PMC 2017 May 01.

Mohan et al.

Page 8

Author Manuscript

the cell fate by regulating the timing from cell proliferation to differentiation during active
wound healing process in the cornea. Our future studies will test this hypothesis.
In summary, this is the first report of Id proteins (Id1–Id4) in the human corneal tissues. Id1
and Id2 proteins are ubiquitously expressed by the corneal epithelial cells and stromal
keratocytes in human cornea except Id1 which was localized in the basal epithelial cells. We
also identified selective expression of Id1 and Id2 in undifferentiated corneal fibroblasts. In
addition, Id1–Id4 genes were differentially expressed in a time-dependent manner in the
presence of TGFβ1 or BMP7 treatments. We found that Id proteins, Id1 and Id2 are activated
in the HCF with TGFβ1 treatment in the presence of BMP7 indicating their role in wound
healing mechanism. Future studies involving elucidating the role of Id proteins in fibroblast
activation or their de-differentiation into myofibroblasts may contribute to the development
of therapeutic options for the modulation of corneal fibrosis and vision impairment.
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Fig. 1.
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Id1 and Id2 are expressed in human cornea and localized in the epithelium, stromal
keratocytes and endothelial layers: Immunofluorescence showing Id1 (A, C, E) and Id2 (B,
D, F) expression in normal human corneal cross sections. Id1 and Id2 were detected in
epithelial, stromal and endothelial cells of the cornea. Arrows indicate Id1 and Id2 positive
keratocytes in the stroma. All panels used DAP1 (blue) for nuclear staining and green + cells
show Id1 and Id2.
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Fig. 2.

Primary human corneal fibroblasts (HCF) expressed all the members of mammalian Id
genes: Representative image showing detection of Id1, Id2, Id3 and Id4 mRNA expression in
human corneal fibroblasts with RT-PCR. β-actin was used as internal control. Average of
each Id gene expression data by RT-PCR was plotted.
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Fig. 3.

Id proteins are selectively expressed in corneal fibroblasts (thin arrow) and not in
myofibroblasts (thick arrow): Human corneal fibroblasts were prepared growing in medium
containing serum whereas myofibroblasts were obtained by culturing HCF in the presence of
transforming growth factor beta 1 (TGFβ1 5 ng/ml) under serum-free condition. Cells were
stained with Id1 (A), α-SMA (B), and Id1 + α-SMA (C) showing distinct staining for each
other and no co-localization was observed. Similarly, Id2 (D), α-SMA (E), and Id2 + αSMA (F) staining showed similar pattern of staining. All panels used DAP1 for nuclear
staining (Id1 and Id2 = green, α-SMA = Red, DAPI = Blue).

Author Manuscript
Author Manuscript
Exp Eye Res. Author manuscript; available in PMC 2017 May 01.

Mohan et al.

Page 13

Author Manuscript
Author Manuscript
Author Manuscript

Fig. 4.

Id genes are differentially expressed by TGFβ in a time-dependent manner: HCF were
treated with rhTGFβ1, mRNA was isolated at multiple time points (2 h, 12 h, 24 h and 48 h)
and analyzed with qRT-PCR. Each gene [(A) Id1, (B) Id2, (C) Id3, (D) Id4] displayed
distinct time-dependent changes in expression (Id1, p < 0.001; Id2, p < 0.01 and Id4, p <
0.001).
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Fig. 5.

Id genes are differentially expressed by BMP7 in a time-dependent manner: HCF were
treated with BMP7, and mRNA was isolated at multiple time points (2 h, 12 h, 24 h and 48
h), and analyzed with qRT-PCR. Each gene [(A) Id1, (B) Id2, (C) Id3, (D) Id4] displayed
distinct time dependent changes in expression (24 h, p < 0.005; 48 h, p < 0.001), Id2 (24 h, p
< 0.01) and Id3 48 h (p < 0.001).
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Fig. 6.

Id genes are differentially expressed by TGFβ and BMP7: Human corneal fibroblasts were
treated with TGFβ1 + BMP7, mRNA was isolated, and subjected to qRT-PCR. TGFβ1 +
BMP7 showed significant additive effect on Id1 expression (p < 0.01).
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Fig. 7.

BMP7 stimulates Id protein expression in the presence of TGFβ1: TGFβ1 and BMP7
treatment increases Id1 and Id2 protein expression in HCF. HCF cells treated with TGFβ1,
BMP7 and TGFβ1 + BMP7 were analyzed by western blot using anti-Id1, anti-Id2, α-SMA
and anti-β-actin antibodies (vehicle denotes no treatment). Quantitation of protein expression
data is also presented in this figure.
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Oligonucleotide primers used for RT-PCR.
Gene

Forward primer sequence 5′–3′

Reverse primer sequence 5′–3′

Product size

Accession number

Id1

GTG CGC TGT CTG TCT GAG

CAA CTG AAG GTC CCT GAT GTA G

228bp

NM_002165.3

Id2

ATG AAC GAC TGC TAC TCC AAG

GCA AGG ACA GGA TGC TGA TA

232bp

NM_002166.4

Id3

CGA CAT GAA CCA CTG CTA CTC

TCG TTG GAG ATG ACA AGT TCC

213bp

NM_002167.4

Id4

GTG CGA TAT GAA CGA CTG CTA

AGT GAC GCG AGT TGT GGC

241bp

NM_001546.3
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Oligonucleotide primers used for qRT-PCR.
Gene

Forward primer sequence 5′–3′

Reverse primer sequence 5′–3′

Size

Accession number

Id1

GCT GTT ACT CAC GCC TCA A

CAA CTG AAG GTC CCT GAT GTA G

110bp

NM_002165.3

Id2

CAA GAA GGT GAG CAA GAT GGA

GGT GAT GCA GGC TGA CAA TA

104bp

NM_002166.4

Id3

CGA CAT GAA CCA CTG CTA CTC

GAT GAC GCG CTG TAG GAT TT

97bp

NM_002167.4

Id4

GGG AAG AGC AGA AGT TAG AGA AA

ACC TCA GGG TGT TGG TTA TTC

96bp

NM_001546.3

SMA

TGG GTG ACG AAG CAC AGA GC

CTT CAG GGG CAA CAC GAA GC

138bp

NM_001613

β-actin

CGG CTA CAG CTT CAC CAC CA

CAG GCA GCT CGT AGC TCT TC

143bp

x00351
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